Elevated HIF-1α levels correlate with advanced tumor stage and poor clinical outcomes, emphasizing the clinical importance of miR-21’s interaction with hypoxia pathways in NSCLC growth. Here, HIF1A is linked to non-small cell lung carcinoma.